Perspectives on sipuleucel-T: Its role in the prostate cancer treatment paradigm

Perspectives on sipuleucel-T: Its role in the prostate cancer treatment paradigm

Sipuleucel-T is an autologous cellular immunotherapy approved in the US for patients with asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer (mCRPC). This significant advance for mCRPC treatment provides healthcare professionals with another effective therapy to ex...

Full description

Saved in:
Bibliographic Details
Main Authors: James L. Gulley, Peter Mulders, Peter Albers, Jacques Banchereau, Michel Bolla, Klaus Pantel, Thomas Powles
Format: Article
Language:English
Published: Taylor & Francis Group 2016-04-01
Series:OncoImmunology
Subjects:
Clinical trials
immune responses
immunotherapy
prostate cancer
sipuleucel-T
Online Access:https://www.tandfonline.com/doi/10.1080/2162402X.2015.1107698
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items